Teresa García-Berrocoso1, Dolors Giralt, Alejandro Bustamante, Thorleif Etgen, Jesper K Jensen, Jagdish C Sharma, Kensaku Shibazaki, Ayhan Saritas, Xingyong Chen, William N Whiteley, Joan Montaner. 1. From the Neurovascular Research Laboratory (T.G.-B., D.G., A.B., J.M.), Vall d'Hebron Institute of Research, Universitat Autònoma de Barcelona, Spain; Department of Neurology (T.E.), Kliniken Südostbayern-Klinikum Traunstein, Germany; Department of Psychiatry and Psychotherapy (T.E.), Technische Universität München, Germany; Department of Cardiology (J.K.J.), Odense University, Denmark; Stroke Medicine (J.C.S.), Lincoln County Hospital, University of Nottingham, UK; Department of Stroke Medicine (K.S.), Kawasaki Medical School, Kurashiki City, Okayama, Japan; Department of Emergency Medicine (A.S.), School of Medicine, Duzce University, Turkey; Department of Neurology (X.C.), Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China; and Centre for Clinical Brain Sciences (W.N.W.), University of Edinburgh, UK.
Abstract
OBJECTIVE: To measure the association of B-type natriuretic peptide (BNP) and N-terminal fragment of BNP (NT-proBNP) with all-cause mortality after stroke, and to evaluate the additional predictive value of BNP/NT-proBNP over clinical information. METHODS: Suitable studies for meta-analysis were found by searching MEDLINE and EMBASE databases until October 26, 2012. Weighted mean differences measured effect size; meta-regression and publication bias were assessed. Individual participant data were used to estimate effects by logistic regression and to evaluate BNP/NT-proBNP additional predictive value by area under the receiver operating characteristic curves, and integrated discrimination improvement and categorical net reclassification improvement indexes. RESULTS: Literature-based meta-analysis included 3,498 stroke patients from 16 studies and revealed that BNP/NT-proBNP levels were 255.78 pg/mL (95% confidence interval [CI] 105.10-406.47, p = 0.001) higher in patients who died; publication bias entailed the loss of this association. Individual participant data analysis comprised 2,258 stroke patients. After normalization of the data, patients in the highest quartile had double the risk of death after adjustment for clinical variables (NIH Stroke Scale score, age, sex) (odds ratio 2.30, 95% CI 1.32-4.01 for BNP; and odds ratio 2.63, 95% CI 1.75-3.94 for NT-proBNP). Only NT-proBNP showed a slight added value to clinical prognostic variables, increasing discrimination by 0.028 points (integrated discrimination improvement index; p < 0.001) and reclassifying 8.1% of patients into correct risk mortality categories (net reclassification improvement index; p = 0.003). Neither etiology nor time from onset to death affected the association of BNP/NT-proBNP with mortality. CONCLUSION: BNPs are associated with poststroke mortality independent of NIH Stroke Scale score, age, and sex. However, their translation to clinical practice seems difficult because BNP/NT-proBNP add only minor predictive value to clinical information.
OBJECTIVE: To measure the association of B-type natriuretic peptide (BNP) and N-terminal fragment of BNP (NT-proBNP) with all-cause mortality after stroke, and to evaluate the additional predictive value of BNP/NT-proBNP over clinical information. METHODS: Suitable studies for meta-analysis were found by searching MEDLINE and EMBASE databases until October 26, 2012. Weighted mean differences measured effect size; meta-regression and publication bias were assessed. Individual participant data were used to estimate effects by logistic regression and to evaluate BNP/NT-proBNP additional predictive value by area under the receiver operating characteristic curves, and integrated discrimination improvement and categorical net reclassification improvement indexes. RESULTS: Literature-based meta-analysis included 3,498 stroke patients from 16 studies and revealed that BNP/NT-proBNP levels were 255.78 pg/mL (95% confidence interval [CI] 105.10-406.47, p = 0.001) higher in patients who died; publication bias entailed the loss of this association. Individual participant data analysis comprised 2,258 stroke patients. After normalization of the data, patients in the highest quartile had double the risk of death after adjustment for clinical variables (NIH Stroke Scale score, age, sex) (odds ratio 2.30, 95% CI 1.32-4.01 for BNP; and odds ratio 2.63, 95% CI 1.75-3.94 for NT-proBNP). Only NT-proBNP showed a slight added value to clinical prognostic variables, increasing discrimination by 0.028 points (integrated discrimination improvement index; p < 0.001) and reclassifying 8.1% of patients into correct risk mortality categories (net reclassification improvement index; p = 0.003). Neither etiology nor time from onset to death affected the association of BNP/NT-proBNP with mortality. CONCLUSION: BNPs are associated with poststroke mortality independent of NIH Stroke Scale score, age, and sex. However, their translation to clinical practice seems difficult because BNP/NT-proBNP add only minor predictive value to clinical information.
Authors: Gustavo Saposnik; Moira K Kapral; Ying Liu; Ruth Hall; Martin O'Donnell; Stavroula Raptis; Jack V Tu; Muhammad Mamdani; Peter C Austin Journal: Circulation Date: 2011-02-07 Impact factor: 29.690
Authors: Joan Montaner; Mila Perea-Gainza; Pilar Delgado; Marc Ribó; Pilar Chacón; Anna Rosell; Manolo Quintana; Mauricio E Palacios; Carlos A Molina; José Alvarez-Sabín Journal: Stroke Date: 2008-06-05 Impact factor: 7.914
Authors: William Whiteley; Caroline Jackson; Steff Lewis; Gordon Lowe; Ann Rumley; Peter Sandercock; Joanna Wardlaw; Martin Dennis; Cathie Sudlow Journal: PLoS Med Date: 2009-09-08 Impact factor: 11.069
Authors: Mary Cushman; Suzanne E Judd; Virginia J Howard; Brett Kissela; Orlando M Gutiérrez; Nancy S Jenny; Ali Ahmed; Evan L Thacker; Neil A Zakai Journal: Stroke Date: 2014-04-22 Impact factor: 7.914
Authors: Katherine M Duello; Jay P Nagel; Colleen S Thomas; Joseph L Blackshear; William D Freeman Journal: Neurocrit Care Date: 2015-08 Impact factor: 3.210
Authors: Stefan Greisenegger; Helen C Segal; Annette I Burgess; Debbie L Poole; Ziyah Mehta; Peter M Rothwell Journal: Stroke Date: 2015-02-03 Impact factor: 7.914